Low Molecular weight heparin
Showing 51 - 75 of >10,000
Pulmonary Embolism, Pulmonary Thromboembolisms, Embolism, Pulmonary Trial in Tehran (Conventional catheter-directed thrombolysis
Terminated
- Pulmonary Embolism
- +3 more
- Conventional catheter-directed thrombolysis (CDT) with recombinant tissue plasminogen activator (rtPA)
- Enoxaparin
-
Tehran, Iran, Islamic Republic ofRajaie Cardiovascular Medical and Research Center
Dec 28, 2021
SARS-COV2 Infection, COVID-19 Disease, Hospitalized Patients Trial in Ioánnina (low molecular weight Heparin as standard of care
Completed
- SARS-COV2 Infection
- +2 more
- low molecular weight Heparin as standard of care treatment
-
Ioánnina, Epirus, GreeceUniversity General Hospital of Ioannina
Sep 27, 2021
Fetal Growth Retardation, Prematurity, Pre-Eclampsia Trial in Lisboa (subcutaneous Enoxaparin, standard of care)
Not yet recruiting
- Fetal Growth Retardation
- +2 more
- subcutaneous Enoxaparin
- standard of care
-
Lisboa, PortugalCentro de Diagnóstico Pré-Natal, Maternidade Dr. Alfredo da Cost
Jul 12, 2021
Blood Clot, Trauma Trial in Canada, United States (Acetylsalicylic acid, Low Molecular Weight Heparin (LMWH))
Completed
- Blood Clot
- Trauma
- Acetylsalicylic acid
- Low Molecular Weight Heparin (LMWH)
-
Tucson, Arizona
- +20 more
Oct 7, 2022
Deep Venous Thrombosis, Pulmonary Embolism Trial in Worldwide (Low dose nadroparin, Intermediate dose nadroparin, Low dose
Completed
- Deep Venous Thrombosis
- Pulmonary Embolism
- Low dose nadroparin
- +7 more
-
New York, New York
- +71 more
May 21, 2022
Pneumonia, Viral Trial in Reus, Barcelona, Madrid (radiation, drug, device)
Recruiting
- Pneumonia, Viral
- Low-dose radiotherapy
- +7 more
-
Reus, Tarragona, Spain
- +2 more
Jul 29, 2021
Venous Thromboembolism, Lung Tumor Trial in France (Tinzaparin Sodium)
Terminated
- Venous Thromboembolism
- Lung Neoplasm
- Tinzaparin Sodium
-
Rennes, Bretagne, France
- +26 more
Nov 14, 2022
Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO
Completed
- COVID-19
- Hypercoagulability
- Low Molecular Weight Heparin
-
Padova, ItalyGiuseppe Camporese
Mar 17, 2021
Venous Thrombosis, Tumors Trial in Minneapolis, Columbus, Milwaukee (Heparin, Low-Molecular-Weight, or direct oral
Completed
- Venous Thrombosis
- Neoplasms
- Heparin, Low-Molecular-Weight, or direct oral anticoagulants
-
Minneapolis, Minnesota
- +2 more
Apr 26, 2022
Diabetes, Type I Trial in Oslo, Stockholm, Uppsala (Low Molecular Weight Sulfated Dextran (LMW-SD), Heparin, CellCept®
Completed
- Diabetes Mellitus, Type I
- Low Molecular Weight Sulfated Dextran (LMW-SD)
- +8 more
-
Oslo, Norway
- +2 more
Sep 22, 2021
Acute Coronary Syndromes Trial in Brighton (Conservative Arm, Invasive Arm)
Completed
- Acute Coronary Syndromes
- Conservative Arm
- Invasive Arm
-
Brighton, United KingdomRoyal Sussex County Hospital
Jan 26, 2021
Cancer, Venous Thromboembolism, Obesity Trial in Canada (Dalteparin)
Recruiting
- Cancer
- +2 more
- Dalteparin
-
Edmonton, Alberta, Canada
- +4 more
Jan 12, 2021
Antiphospholipid Syndrome in Pregnancy, Pregnancy Loss Trial in Ottawa (Aspirin 81 mg, Low-molecular-weight heparin)
Terminated
- Antiphospholipid Syndrome in Pregnancy
- Pregnancy Loss
- Aspirin 81 mg
- Low-molecular-weight heparin
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Mar 25, 2020
Infertility Trial in Shenzhen, Wuhan, Nanjing (Low Molecular Weight Heparin (enoxaparin sodium))
Unknown status
- Infertility
- Low Molecular Weight Heparin (enoxaparin sodium)
-
Shenzhen, Guangdong, China
- +2 more
Jul 27, 2020
Anticoagulant, Venous Thromboembolism, Prophylaxis Trial in Denmark (Dalteparin Prefilled Syringe, Tinzaparin profiled syringe)
Recruiting
- Anticoagulant
- +3 more
- Dalteparin Prefilled Syringe
- Tinzaparin profiled syringe
-
Copenhagen, Denmark
- +8 more
Aug 29, 2023
Thromboprophylaxis for Patients in ICU With COVID-19
Completed
- Covid19
- +2 more
-
Zaragoza, Aragón, Spain
- +30 more
Mar 29, 2022
Pulmonary Embolism Trial in Mainz (Dabigatran)
Terminated
- Pulmonary Embolism
-
Mainz, GermanyCenter for Thrombosis and Hemostasis, University Medical Center
Feb 12, 2020
Spinal Cord Injuries, Venous Thromboembolism Trial in Hamilton (Apixaban, Low molecular weight heparin)
Terminated
- Spinal Cord Injuries
- Venous Thromboembolism
- Apixaban
- Low molecular weight heparin
-
Hamilton, Ontario, CanadaHamilton General Hospital
Feb 18, 2020
VTE and Higher Hypercoagulability in Patients Recovered in ICU
Completed
- COVID-19 Disease
- Thromboembolism, Venous
- thromboprophylaxis with low-molecular-weight heparin or fondaparinux
-
Padova, ItalyGiuseppe Camporese
Sep 15, 2020
Restart Anticoagulation in Spontaneous Intracerebral Hemorrhage
Unknown status
- Cerebral Hemorrhage
- Low molecular weight heparin
-
Hangzhou, Zhejiang, China
- +1 more
Jun 26, 2020